POSTER: CML-532 ASC4KIDS: A Multicenter, Open-Label, Phase 1b/2 Study to Determine the Dose and Safety of Asciminib in Pediatric Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP)

Hijiya, N., Heneghan, M., Kapoor, S., Dhamal, V., Hoch, M., Descamps, L., Cardoso, A. P., & Pollard, J. (2023). POSTER: CML-532 ASC4KIDS: A Multicenter, Open-Label, Phase 1b/2 Study to Determine the Dose and Safety of Asciminib in Pediatric Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP). Clinical Lymphoma Myeloma and Leukemia, 23, S180. https://doi.org/10.1016/s2152-2650(23)00574-8
Authors:
Nobuko Hijiya
Mallorie B. Heneghan
S. S. Kapoor
Vishal Dhamal
Matthias Hoch
Laurence Descamps
Ana Paula Cardoso
Jessica A. Pollard
Affiliated Authors:
Nobuko Hijiya
Columbia Affiliation:
Subjects:
Efficacy and Resistance in CML Treatment (OpenAlex Topic)
Genomic Aberrations and Treatment of Chronic Lymphocytic Leukemia (OpenAlex Topic)
Advancements in Lung Cancer Research (OpenAlex Topic)
elink
Publication Type:
Article
Unique ID:
10.1016/s2152-2650(23)00574-8
DOI:
10.1016/s2152-2650(23)00574-8
Journal:
Clinical Lymphoma, Myeloma and Leukemia
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record

Record Created: